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Introduction
Allergic reactions are aberrant immune responses 
to exogenous, normally harmless substances (al-
lergens from, e.g., pollen, house dust mites, ani-
mal dander, insect venom, food components). In 
type-I (immediate-type) allergies, specific immu-
noglobulin E (IgE) antibodies react with allergens 
and trigger allergic reactions. The presence of IgE 
antibodies (in blood and on some skin and muco-
sa cells, e.g., mast cells) is an absolute precondi-
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Abstract
The lifetime prevalence of allergic diseases in adults 
in Germany [self-reported doctor diagnosed aller-
gic diseases, Study on Adult Health in Germany 
(Studie zur Gesundheit Erwachsener in Deutsch-
land, DEGS1, 2008–2011) of the Robert Koch Insti-
tute] is 8.6 % for asthma, 14.8 % for hay fever, 3.5 % 
for atopic dermatitis, 8.1 % for contact dermatitis, 
4.7 % for food allergies, and 2.8 % for insect venom 
allergies. Almost 20 % of German adults are cur-
rently affected by at least one allergy.
In tests on 50 common single allergens and two 
mixtures comprising either inhalant allergens or 
grass pollen allergens, 48.6 % of participants ex-
hibited at least one allergic sensitization (specific 
IgE antibody detection). Overall, 33.6 % of partic-
ipants were sensitized to inhalant allergens, 25.5 % 
to at least one food allergens, and 22.6 % to at least 
one insect venom allergens. A comparison of data 
on adults from 1998 [Federal Health Survey 1998 
(Bundes-Gesundheitssurvey 1998, BGS98) of the 
Robert Koch Institute] and 2008–2011 (DEGS1) 
shows an increase in prevalence over time of al-
most three percentage points, while the rate of sen-
sitization to inhalant allergens has increased from 
29.8 % to 33.6 %. The prevalence of doctor diag-
nosed hay fever, atopic dermatitis, and food aller-
gies, on the other hand, has remained virtually un-
changed over the last 15 years.
The Germany-wide lifetime prevalence of allergic 
diseases in children and adolescents [Study on the 
Health of Children and Adolescents in Germany (Stud-
ie zur Gesundheit von Kindern und Jugendlichen in 
Deutschland, KiGGS initial survey, 2003–2006) of the 
Robert Koch Institute] was 4.7 % for asthma, 10.7 % for 
hay fever, and 13.2 % for atopic dermatitis. Altogether, 
40.8 % of German children and adolescents were sen-
sitized to at least one of the inhalant or food allergens 
measured, while 20.0 % were sensitized to at least one 
food allergen. A marked increase in hay fever preva-
lence among East German children in the 1990s has 
resulted in an alignment of prevalence rates in East and 
West Germany. In contrast to adults, there was no lon-
ger a discernible difference in the prevalence of asthma, 
hay fever, and allergic sensitization in children between 
the western and eastern German federal states.
In international comparisons with prevalence data 
from other studies, the participating German cen-
ters are in the lower third of the distribution of fre-
quency for both children and adults.
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tion for the clinical manifestation of allergy in this 
allergy type. The presence of specific IgE antibod-
ies is referred to as allergic sensitization. Sensiti-
zation is the precondition for an allergy, i.e., the 
onset of allergic symptoms; however, it may also 
be present without leading to symptom onset 
upon contact with the allergen. The prevalence of 
sensitizations to certain allergens has increased in 
recent years.
Unfortunately, a straightforward answer to the 
question of the prevalence of allergic diseases in 
Germany is not possible, since:
— There is, to an extent, no generally accepted 
definition of the various forms of allergic diseas-
es (e.g., asthma is often classified as an allergy, 
although many cases involve non-allergic rather 
than allergic asthma).
— It is virtually impossible to collect epidemiologi-
cal data on these specific disease entities in large 
population-based studies.
— Routine data are unavailable or insufficiently 
valid.
— The availability of data deemed representative of 
the German population is poor.
Thus, most large epidemiological surveys are re-
stricted to answering simple questions such as 
those relating to the doctor diagnosis of asthma, 
hay fever, and atopic dermatitis, or gathering data 
on key symptoms, such as wheezing respiratory 
sounds, eye redness and irritation in the absence of 
cold symptoms, pruritic skin rash, which appears 
for some weeks and then disappears for a certain 
period. An assessment of bronchial hyperreactivi-
ty of the airways to a nonspecific irritant with re-
peat pulmonary function tests and the determina-
tion of allergic sensitization by skin prick testing or 
specific serum IgE detection, as well as standard-
ized skin examination according to SCORAD 
(scoring atopic dermatitis) to assess the severity of 
eczema, yield more objective data. An immune dys-
function is always present in the case of allergy; this 
can be determined with skin or blood tests. In con-
trast, food allergies or intolerances can only be de-
tected by means of specific food challenge testing. 
Tests of this kind are complex and are rarely per-
formed in the general population. Therefore, reli-
able data on the prevalence of these diseases are 
largely lacking. However, the risk (not the disease 
itself!) of food allergies can be determined in blood 
by detecting specific immunoglobulins (IgE) to 
food allergens.
The prevalence of allergic disease in 
Germany
The prevalence data presented in this position paper 
pertain to the general German population. The lit-
erature search was restricted to only those national 
surveys that included the entire population of the 
Federal Republic of Germany, in order to exclude 
the possibility of specific regional data not related 
to the entire German population. The surveys in-
cluded were those conducted in children and adults 
under the direction of the Robert Koch Institute in 
recent years.
Adults
Prevalence estimates representative for Germany 
were obtained from the Study on Adult Health in 
Germany (Studie zur Gesundheit Erwachsener in 
Deutschland, DEGS1) last conducted between 2008 
to 2011 (Fig. 1). Data was collected from 7988 18- to 
79-year-olds using computer-aided medical inter-
views at participation rates of 42 % and 62 % in the 
population initially invited and the follow-up pop-
ulation of the BGS98, respectively. According to 
these data, the lifetime prevalence of doctor diag-
nosed allergic disease is 8.6 % for asthma, 14.8 % for 
hay fever, 3.5 % for atopic dermatitis and for urti-
caria, 8.1 % for contact dermatitis, 4.7 % for food al-
lergies, and 2.8 % for insect venom allergies [1].
Altogether, at least one of the above-mentioned 
allergies has been diagnosed in almost a third of 
German adults at some point. Almost 20 % of Ger-
man adults are currently affected by at least one 
allergy. In general, women are more frequently af-
fected than men and younger women more fre-
quently than older. In addition, allergies are more 
prevalent in the western federal states compared 
Fig. 1: Lifetime prevalence of medically diagnosed allergic diseases (self- 
reported) in adults (18–79 years, RKI survey DEGS1, survey period  
11/2008–11/2011, n=7988 [1]) and children/adolescents (0–17 years, RKI survey 
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to the eastern. Higher socioeconomic status and 
living in large urban areas likewise increase dis-
ease prevalence.
Also as part of this study, specific IgE antibodies to 
50 widespread single allergens were measured and 
two tests performed, each using a mixture of inha-
lant allergens (composition: timothy, rye, birch, 
mugwort, house dust mite, cat dander, dog dander, 
Cladosporium herbarum) and grass pollen allergens 
(composition: cocksfoot, meadow fescue, darnel, 
 timothy,  bluegrass) (Fig. 2, Fig. 3). Sensitization was 
detected in 48.6 % of participants. More men com-
pared to women were sensitized to at least one all-
ergen. In addition, more of the younger participants 
compared with the older, as well as more subjects 
with a higher social status, were affected by at least 
one sensitization. Altogether, 33.6 % of participants 
were sensitized to inhalant allergens, 25.5 % to at 
least one food allergen, and 22.6 % to at least one in-
sect venom [2].
Children
Allergy prevalence data representative for the 
whole of Germany were collected between 2003 
and 2006 in the German „Children and Adoles-
cent Health Survey“ (Kinder- und Jugend-Ge-
sundheitssurvey, KiGGS) (Fig. 1). At a participa-
tion rate of 66.6 %, 17,641 children and adoles-
cents aged between 0 and 17 years were investigat-
ed. Interviews and questionnaires relating to doc-
tor diagnosed diseases yielded a lifetime preva-
lence of 4.7 % for asthma, 10.7 % for hay fever, and 
13.2 % for atopic dermatitis [3, 4]. Of the study par-
ticipants, 40.8 % were sensitized to at least one of 
the 20 inhalant or food allergens measured (Fig. 
2). With the exception of eczema, a marked in-
crease in atopic disease was seen with age, indicat-
ing that age-specific prevalence data are more 
meaningful. Boys were more frequently affected 
by asthma, hay fever, and specific sensitizations 
compared to girls. There is no longer a discernible 
difference between western and eastern German 
federal states. Children from families of lower so-
cioeconomic status or with a background of mi-
gration are significantly less frequently affected by 
allergic disease [4]. The follow-up study of 12,368 
children and adolescents in the KiGGS Wave-1 
survey conducted between 2009 and 2012 as a 
combined cross-sectional and longitudinal survey 
largely confirmed these figures (the lifetime prev-
alence of doctor diagnosed diseases was 6.3 % for 
asthma, 12.6 % for hay fever, and 14.3 % for atopic 
dermatitis) [5].
As in other large epidemiological studies, the es-
timates on the prevalence of allergic disease in both 
the KiGGS and DEGS are essentially based on sur-
veying doctor diagnoses and not on the standard-
ized collection of data on key symptoms or even ob-
jective clinical tests; the real burden of disease, 
therefore, may be underestimated.
In international comparison with prevalence data 
from the ISAAC study (The International Study of 
Asthma and Allergies in Childhood) in children 
and the ECRHS (European Community Respirato-
ry Health Survey) in adults in numerous other 
countries, prevalence estimates for asthma, hay fe-
ver, and eczema at the participating German centers 
are in the lower third of the distribution of preva-
lence for both children and adults [6, 7].
A marked increase in the prevalence of hay fever 
and allergic sensitization was seen in adults (partic-
ularly young adults) during the 1990s. The increase 
in asthma was less pronounced [8, 9]. In a compar-
ison between the German Federal Health Survey of 
1998 (BGS98) and the first wave of the DEGS survey 
(2008–2011), the prevalence of asthma has risen by 
just under a further three percentage points, while 
allergic sensitization to inhalant allergens has risen 
from 29.8 % to 33.6 % [2]. In contrast, the frequency 
of medically diagnosed hay fever, atopic dermatitis, 
and food allergies has remained virtually unaltered 
over the last 15 years. 
A marked rise in the prevalence of hay fever, al-
lergic sensitization, and asthma was seen in partic-
ular in East German children in the 1990s. This 
marked rise resulted in an alignment of prevalence 
Fig. 2: Prevalence of sensitization to specific allergens in adults (18–79 years, 
RKI survey DEGS1, survey period 11/2008–11/2011, n=7025 [2]) and children/
adolescents (3–17 years, RKI survey KiGGS, survey period 05/2003–05/2006, 
n=12,988 [4, 12]). The panels tested are not identical: In the adult group, blood 
samples were analyzed for specific IgE antibodies to 50 widespread single 
 allergens, and two tests performed, each using a mixture of inhalant allergens 
(SX1) and grass pollen (GX1). In the child/adolescent group, blood samples 
were analyzed for specific IgE antibodies to 20 single allergens and tests 
 performed with a mixture of inhalant allergens (SX1).
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rates in children in East and West Germany. In con-
trast to adults, there is no longer a discernible dif-
ference in the prevalence rates of asthma, hay fever, 
and allergic sensitization in children between the 
old and new German federal states.
The comparison of 12-month prevalence rates of 
atopic diseases between KiGGS survey period 1 and 
KiGGS baseline survey 6 years earlier (cross-sec-
tional comparison) indicates that the frequency of 
asthma is increased in children and adolescents 
with no significant increase of hay fever either; the 
12-month prevalence rates of atopic dermatitis show 
a statistically significant reduction [5].
The sensitizing potential of mold is estimated as 
far lower compared with other environmental aller-
gens, such as grass or tree pollen and mites [10]. 
Current – population- as well as patient-based [11] 
– studies show comparatively low sensitization rates 
of 3 %–10 % throughout Europe [2].
Conclusion
Given that almost every third person in Germany 
is affected by allergic disease in the course of their 
life and that allergic sensitization was detected in 
50 % of the German population, one is compelled to 
classify this phenomenon as an important, frequent, 
and widespread disease that impairs the quality of 
life of many. Any trivialization of the problem is 
wholly misplaced in view of the well-documented 
situation. No primary allergy prevention is in sight. 
Therefore, particularly in terms of our responsibil-
ity to the young generation, it is essential to increase 
efforts on all levels (research, treatment, and admin-
istration) to ensure that the „allergy problem in 
Germany“ is recognized and addressed as a genuine 
problem in the health sector.
Dr. Hildegard Niemann
Specialist Field 24: Health Reporting
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